Peptilogics receives $3.3 million from CARB-X to develop treatment for fracture-related infections
unoL / iStock CARB-X (Combating Antibiotic-Resistant Micro organism Biopharmaceutical Accelerator) yesterday introduced an award of $3.3 million to Pittsburgh-based Peptilogics ...